In a study by Li D. et al. (2018), it was identified that by decreasing NLRP3 inflammasome activation and negatively regulating Nlrp3 expression in the MPTP-induced PD mouse model, miR-30e reduces neuronal injury, neuroinflammation, and dyskinesia. The gene discussed is NLRP3; the disease is drug-induced dyskinesia.